Lavandula angustifolia miller: English lavender

Holistic Nursing Practice

Volumn 23, Issue 1, 2009, Pages 57-64

  Denner, Sallie Stoltz ^a,b,c  

^a DREXEL UNIVERSITY   (United States)

^b St Joseph Medical Center   (United States)

^c NONE   (United States)

Author keywords

English lavender; Lavandula angustifolia

Indexed keywords

ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ESSENTIAL OIL; HYPNOTIC SEDATIVE AGENT; VEGETABLE OIL;

ADULT; ANIMAL; CHEMISTRY; CHILD; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG INTERACTION; DRUG SCREENING; EVIDENCE BASED PRACTICE; HUMAN; LAVENDER; METHODOLOGY; PHYTOTHERAPY; REVIEW; SAFETY; WOUND HEALING;

ADULT; ANALGESICS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIHYPERTENSIVE AGENTS; CHILD; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; EVIDENCE-BASED PRACTICE; HUMANS; HYPNOTICS AND SEDATIVES; LAVANDULA; OILS, VOLATILE; PHYTOTHERAPY; PLANT OILS; RESEARCH DESIGN; SAFETY; WOUND HEALING;

EID: 60849135465     PISSN: 08879311     EISSN: 15505138     Source Type: Journal    
DOI: 10.1097/01.HNP.0000343210.56710.fc     Document Type: Article

References (50)

1. Anonymous. Expanded German Commission E. Lavandula angustifolia, 2000. http://www.herbalgram.org/abc/herbalmedicine/ default.asp?m-56. Accessed April 14, 2007.
2. Basch E, Foppa I, Liebowitz R, et al. Monograph from National Standard: lavender (Lavandula angustifoliaMiller). J Herbal Pharmacother. 2004;4(2):63-78.
3. Cavanagh H, Wilkinson J. Biological activities of lavender essential oil. Phytother Res. 2002;16:301-308.
4. Price S, Price L. Aromatherapy for Health Professionals. 3rd ed. Philadelphia, PA: Churchill, Livingstone, Elsevier; 2007.
5. Hajhashemi V, Ghannadi A, Sharif B. Anti-inflammatory and analgesic propertiesof the leaf extracts and essential oil of Lavandula angustifolia Mill. J Ethnopharmacol. 2003;89(1):67-71.
6. Higley C, Higley A. Reference Guide for Essential Oils. 2nd ed. Olathe, KS: Abundant Health; 2001.
7. Glenn L. Lavender - one of the safest and most versatile essential oils. American Botanical Council. http://www.herbalgram.org/default.asp?c =hcnews294. Accessed April 24, 2007.
8. Anonymous (2000).
9. Anonymous. Lavender. American Botanical Council, 2007. http://www. herbalgram. org/abc/healthyingredients/default.asp?h=Lavender. Accessed May 17, 2007.
10. Food and Drug Administration: Department of Health and Human Services. Substances Generally Recognized as Safe (§ 21CFR182.20). Washington, DC: U.S. Government Printing Office, p. 459, 1985. http://frwebgate3.access. gpo.gov/cgi-bin/PDFgate.cgi?/WAISdocID= 63586819194+3+2+0&WAISaction= retrieve. Accessed November 2, 2008.
11. Fakhari AR, Salehi P, Heydari R, Ebrahimi SN, Haddad PR. Hydrodistillation-headspace solvent microextraction, a new method for analysis of the essential oil components of Lavandula angustifolia Mill. J Chromatogr A. 2005;1098(1-2):14-18.
12. Prasher A, Locke IC, Evans CS. Cytotoxicity of lavender oil and its major components to human skin cells. Cell Prolif. 2004;37:221-299.
13. Atsumi T, Tonosaki K. Smelling lavender and rosemary increases free radical scavenging activity and decreases cortisol level in saliva. Psychiatry Res. 2007;150(1):89-96.
14. Lis-Balchin M, Hart S. Studies on the mode of action of the essential oil of lavender (Lavandula angustifolia P. Miller). Phytotherapy Res. 1999;13:540-542.
15. Buchbauer G, Jirovetz L, Jäger W,Deitrich H, Plank C, Karamat E.Aro-matherapy: evidence for sedative effects of the essential oil of lavender after inhalation. Z Naturforsch. 1991;46(11-12):1067-1072.
16. ElisabetskyE,MarschnerJ,Souza DO. Effectsoflinaloolonglutamater-gic system in the rat cerebral cortex. Neurochem Res. 1995;20(4):461- 465.
17. Ghelardini C, Galeotti N, Salvatore G, Mazzanti G. Local anaesthetic activity of the essential oil of Lavandula angustifolia. Planta Med. 1999;65(8):700-703.
18. Re L, Barocci S, Sonnino S, et al. Linalool modifies the nicontinic receptor-ion channel kinetics at the mouse neuromuscular junction. Pharmacol Res. 2000;42(2):177-182.
19. Santos FA, Rao VSN. Anti-inflammatory and antiociceptive effects of 1,8-cineole, a terpenoid oxide present in many plant essential oils. Phytother Res. 2000;14(4):240-244.
20. Hohmann J, Zupko I, Redei D, et al. Protective effects of the aerial parts of Salvia officinalis, Melissa officinalis and Lavandula augustifolia and their constituents against enzyme-dependent and enzyme- independent lipid peroxidation. Planta Med. 1999;65(6):576-578.
21. Jaswal S, Mehta H, Sood A, Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta. 2003;338(1- 2):123-129.
22. Brenner DE. Cancer chemoprevention. Curr Opin Gastroenterol. 1999;15(1):9.
23. Da Fonseca CO, Masini M, Futuro D, Caetano R, Gattass CR, Quirico-Santos T. Anaplastic oligodendroglioma responding favorably to in-tranasal delivery of perillyl alcohol: a case report and literature review. Surg Neurol. 2006;66(6):611-615.
24. Wiseman DA, Werner SR, Crowell PL. Cell cycle arrest by the iso- prenoids perillyl alcohol, geraniol, and farnesol is mediated by p21 (Cip1) and p27 (Kip1) in human pancreatic adenocarcinoma cells. J Pharmacol Exp Ther. 2007;320:1163-1170.
25. Zald DH, Pardo JV. Functional neuroimaging of the olfactory system in humans. Int J Psychophysiol. 2000;36(2):165-181.
26. Heuberger E, Redhammer S, Buchbauer G. Transdermal absorption of (-) linalool induces autonomic deactivation but has no impact on ratings of well-being in humans. Neuropsychopharmacology. 2004;29:1925-1932.
27. Hudson R. The value of lavender for the rest and activity in the elderly patient. Complement Ther Med. 1996;4:52-57.
28. Brownfield A. Aromatherapy in arthritis: a study. Nurs Stand. 1998;13(5):34-35.
29. Morris N. The effects of lavender (Lavendula angustifolia) baths on psychological well-being: two exploratory randomized control trials. Complement Ther Med. 2002;10:223-228.
30. Louis M, Kowalski S. Use of aromatherapy with hospice patients to decrease pain, anxiety and depression and topromotean increased sense of well-being. Am J Hospice Palliat Care. 2002;19(6):381-386.
31. Gedney J, Glover T, Fillingim R. Sensory and affective pain discrimination after inhalation of essential oils. Psychosom Med. 2004;66:599-606.
32. Koto R, Imamura M, Watanabe C, et al. Linalyl acetate as a major ingredient of lavender essential oil relaxes the rabbit vascular smooth muscle through dephosphorylation of myosin light chain. J Cardiovasc Pharmacol. 2006;48:850-856.
33. Inouye S, Takizawa T, Yamaguchi H. Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J Antimicrob Chemother. 2001;47:565-573.
34. Nelson RRS. In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 1997;40:305-306.
35. Cavanagh H, Wilkinson J. Lavender essential oil: a review. Aust Infect Control. 2005;10(1):35-37.
36. D'Auria FD, TeccaM,StrippoliV,SalvatoreG,BattinelliL,Mazzanti G. Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form. Med Mycol. 2005;43(5):391-396.
37. Sheppard J. Aromatherapy: Using Nature's Healing Oils, 2004. http:// www.hpakids.org/holistic-health/articles/12/1/Aromatherapy/print/12. Accessed May 25, 2007.
38. Henley D, Lipson N, Korach K, Bloch C. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007;356(5):479-485.
39. Peana AT, D'Aquila PS, Panin F, Serra G, Pippia P, Moretti MD. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine. 2002;9(8):721-726.
40. Peana AT, D'Aquila PS, Chessa ML, Moretti MDL, Serra G, Pippia P. (-)-Linalool produces antinociception in two experimental models of pain. Eur J Pharmacol. 2003;460:37-41.
41. Peana AT, De Montis MG, Sechi S, Sircana G, D'Aquila PS, Pippia P. Effects of (-)-linalool in the acute hyperalgesia induced by carrageenan, l-glutamate and prostaglandin E2. Eur J Pharmacol. 2004;497:279-284.
42. Peana AT, Rubattu P, Piga GG, et al. Involvement of adenosine A1 and A2A receptors in (-)-linalool-induced antinociception. Life Sci. 2006;78:2471-2474.
43. Bradley BF, Starkey NJ, Brown SL, Lea RW. Anxiolytic effects of Lavandula angustifolia odouronthe Mongolian gerbil elevated plus maze. J Ethnopharmacol. 2007;111(3):517-525.
44. Tanida M, Niijima A, Shen J, Nakamura T, Nagai K. Olfactory stimulation with scent of lavender oil affects autonomic neurotransmission and blood pressure in rats. Neurosci Lett. 2006;398(1-2):155-160.
45. Peana AT, Marzocco S, Popolo A, Pinto A. (-)-Linalool inhibits in vitro NO formation: probable involvement in the antinociceptive activity of this monoterpene compound. Life Sci. 2006;78:719-723.
46. Evandri MG, Battinelli L, Daniele C, Mastrangelo S, Bolle P, Mazzanti G. The antimutagenic activity of Lavandula angustifolia (lavender) essential oil in the bacterial reverse mutation assay. Food Chem Toxicol. 2005;43:1381-1387.
47. Moon T, Wilkinson J, Cavanagh HM. Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata. Parasitol Res. 2006;99(6):722-728.
48. Snow AL, Hovanec L, Brandt J. A controlled trial of aromatherapy for agitation in nursing home patients with dementia. J Altern Complement Med. 2004;10(3):431-437.
49. Lin PW, Chan WC, Ng BF, Lam LC. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia:a cross-over randomized trial.IntJGeriatr Psychiatry. 2007;22(5):405-410.
50. Kim JT, Wajda M, Cuff G, et al. Evaluation of aromatherapy in treating postoperative pain: pilot study. Pain Practi. 2006;6(4):273-277.